Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bermekimab in moderate to severe plaque psoriasis
NCT01384630Phase 2Completed
- Sponsor
- Janssen Pharmaceutical
- Start
- Sep 2011
- Primary completion
- Jul 2012
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of bermekimab in plaque psoriasis, sponsored by Janssen Pharmaceutical. Started Sep 2011; status: completed.
02
Drugs
bermekimab
03
Conditions
plaque psoriasis
Beyond the preview
Go deeper on NCT01384630.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01384630.